Acrux Limited (AU:ACR) has released an update.
Acrux Limited, a specialty pharmaceutical company, has announced its Annual General Meeting (AGM) for shareholders on 21 November 2024, to be held at Pitcher Partners’ offices in Melbourne. Shareholders are encouraged to participate and vote, with options to appoint a proxy and submit questions in advance. The company, known for developing and commercializing topical pharmaceutical products, particularly in the U.S., invites collaboration and discussions for commercial partnering and product development.
For further insights into AU:ACR stock, check out TipRanks’ Stock Analysis page.
